Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC02796 |
| Type | Targeted Mutation Congenic |
| Species | Mus musculus |
| Strain name | B6.Cg-Stab2<tm1> |
| Former Common name | Stab2-KO |
| H-2 Haplotype | |
| ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
| Background strain | |
| Appearance | |
| Strain development | 2006年樹立TT2 (ES) → CD1(キメラ) → B6 (backcross 7 世代) |
| Strain description | 血中ヒアルロン酸濃度が高い。血液学・生化学・組織学的な異常は見られない。 |
| Colony maintenance | 繁殖効率:Aホモ同士にて維持可能 |
| References | Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis. Yoshikazu Hirose, Eiko Saijou, Yasuyoshi Sugano, Fumitaka Takeshita, Satoshi Nishimura, Hidenori Nonaka, Yen-Rong Chen, Keisuke Sekine, Taketomo Kido, Takashi Nakamura, Shigeaki Kato, Toru Kanke, Koji Nakamura, Ryozo Nagai, Takahiro Ochiya, Atsushi Miyajima Proc. Natl. Acad. Sci. USA, 109(11):4263-4268 (2012). 22371575 |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| Stab2 MGI:2178743 | stabilin 2 | 10 | Stab2 MGI:5318244 | targeted mutation 1 | |||
| lacZ | beta-galactosidase (E. coli) | 10 | |||||
| neo | neomycin resistance gene (E. coli) | 10 | |||||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | |
| Detailed phenotype data | |
Ordering Information | |
|---|---|
| 供与核酸 | PGK promoter (mouse Phosphoglycerate kinase-1 promoter), E. coli lacZ, E. coli neo, mouse Stab2 genomic DNA |
| Research application | Fluorescent Proteins/lacZ System Hematological Research |
| 提供条件 | 利用者は事前に寄託者の提供承諾書を得る。寄託者の承諾を得る。 |
| Depositor | 宮島 篤(国立大学法人東京大学) |
| Strain Status | 凍結胚 凍結精子 |
| Strain Availability | 凍結胚より作出したマウスを2~4ヶ月以内に提供可能 凍結精子を1ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 |
| Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
|---|
Pirie E, Ray S, Pan C, Fu W, Powers AF, Polikoff D, Miller CM, Kudrna KM, Harris EN, Lusis AJ, Crooke RM, Lee RG. Mouse genome-wide association studies and systems genetics uncover the genetic architecture associated with hepatic pharmacokinetic and pharmacodynamic properties of a constrained ethyl antisense oligonucleotide targeting Malat1. PLoS Genet 14(10) e1007732(2018) 30372444 |
Donner AJ, Wancewicz EV, Murray HM, Greenlee S, Post N, Bell M, Lima WF, Swayze EE, Seth PP. Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the Liver. Nucleic Acid Ther 27(4) 209-220(2017) 28448194 |